Search details
1.
Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
Ann Surg
; 277(5): 813-820, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-35797554
2.
Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience.
Oncologist
; 27(11): 952-957, 2022 11 03.
Article
in English
| MEDLINE | ID: mdl-35946836
3.
Acneiform eruptions with combination targeted cancer therapy in colorectal cancer patients.
Support Care Cancer
; 30(10): 8051-8058, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35771289
4.
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy.
Mod Pathol
; 33(9): 1832-1843, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32376853
5.
Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA Profiling.
Cancers (Basel)
; 16(4)2024 Feb 09.
Article
in English
| MEDLINE | ID: mdl-38398128
6.
Truncal Dynamics May Trump: Serial ctDNA to Predict Early Therapeutic Response.
Clin Cancer Res
; 29(2): 302-304, 2023 01 17.
Article
in English
| MEDLINE | ID: mdl-36378102
7.
Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just genetics.
Front Cell Dev Biol
; 11: 1176657, 2023.
Article
in English
| MEDLINE | ID: mdl-37791069
8.
Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer.
JCO Precis Oncol
; 7: e2200422, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37487150
9.
Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy.
J Clin Oncol
; 41(3): 460-471, 2023 01 20.
Article
in English
| MEDLINE | ID: mdl-36351210
10.
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing.
JCO Precis Oncol
; 7: e2300228, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37824798
11.
Survival improvement for patients with metastatic colorectal cancer over twenty years.
NPJ Precis Oncol
; 7(1): 16, 2023 Feb 13.
Article
in English
| MEDLINE | ID: mdl-36781990
12.
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
Cancer Res Commun
; 3(12): 2510-2517, 2023 12 11.
Article
in English
| MEDLINE | ID: mdl-38085001
13.
Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer.
J Gastrointest Oncol
; 13(2): 647-656, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35557581
14.
Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review.
JAMA Netw Open
; 5(5): e2213588, 2022 05 02.
Article
in English
| MEDLINE | ID: mdl-35608860
15.
Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.
JAMA Netw Open
; 5(10): e2236357, 2022 10 03.
Article
in English
| MEDLINE | ID: mdl-36239938
16.
Bintrafusp alfa, an anti-PD-L1:TGF-ß trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer.
Cancer Res Commun
; 2(9): 979-986, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36382087
17.
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
J Immunother Cancer
; 10(8)2022 08.
Article
in English
| MEDLINE | ID: mdl-36007963
18.
Comprehensive Clinical and Molecular Characterization of KRAS G12C-Mutant Colorectal Cancer.
JCO Precis Oncol
; 52021.
Article
in English
| MEDLINE | ID: mdl-34250391
19.
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases.
Clin Cancer Res
; 27(11): 3039-3049, 2021 06 01.
Article
in English
| MEDLINE | ID: mdl-33811152
20.
This Is Our Cells Under Pressure: Decreased DNA Damage Repair in Response to Targeted Therapies Facilitates the Emergence of Drug-Resistant Clones.
Cancer Cell
; 37(1): 5-7, 2020 01 13.
Article
in English
| MEDLINE | ID: mdl-31951562